1. Home
  2. SRDX vs NRIM Comparison

SRDX vs NRIM Comparison

Compare SRDX & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • NRIM
  • Stock Information
  • Founded
  • SRDX 1979
  • NRIM 1990
  • Country
  • SRDX United States
  • NRIM United States
  • Employees
  • SRDX N/A
  • NRIM N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • NRIM Savings Institutions
  • Sector
  • SRDX Health Care
  • NRIM Finance
  • Exchange
  • SRDX Nasdaq
  • NRIM Nasdaq
  • Market Cap
  • SRDX 402.2M
  • NRIM 444.5M
  • IPO Year
  • SRDX 1998
  • NRIM N/A
  • Fundamental
  • Price
  • SRDX $27.75
  • NRIM $21.36
  • Analyst Decision
  • SRDX Buy
  • NRIM
  • Analyst Count
  • SRDX 3
  • NRIM 0
  • Target Price
  • SRDX $43.00
  • NRIM N/A
  • AVG Volume (30 Days)
  • SRDX 113.5K
  • NRIM 112.3K
  • Earning Date
  • SRDX 11-05-2025
  • NRIM 10-22-2025
  • Dividend Yield
  • SRDX N/A
  • NRIM 3.09%
  • EPS Growth
  • SRDX N/A
  • NRIM 38.28
  • EPS
  • SRDX N/A
  • NRIM 2.00
  • Revenue
  • SRDX $120,801,000.00
  • NRIM $175,041,000.00
  • Revenue This Year
  • SRDX N/A
  • NRIM N/A
  • Revenue Next Year
  • SRDX $3.38
  • NRIM $31.22
  • P/E Ratio
  • SRDX N/A
  • NRIM $10.38
  • Revenue Growth
  • SRDX N/A
  • NRIM 28.34
  • 52 Week Low
  • SRDX $26.00
  • NRIM $15.92
  • 52 Week High
  • SRDX $40.39
  • NRIM $25.05
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 29.38
  • NRIM 20.12
  • Support Level
  • SRDX $26.82
  • NRIM $20.70
  • Resistance Level
  • SRDX $28.69
  • NRIM $21.60
  • Average True Range (ATR)
  • SRDX 0.60
  • NRIM 0.66
  • MACD
  • SRDX 0.12
  • NRIM 2.48
  • Stochastic Oscillator
  • SRDX 39.74
  • NRIM 67.04

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About NRIM Northrim BanCorp Inc

Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.

Share on Social Networks: